BRPI0513456A - complexo de tecnécio, conjugado quelador, radiofármaco, kit para a preparação do radiofármaco, e, composto - Google Patents

complexo de tecnécio, conjugado quelador, radiofármaco, kit para a preparação do radiofármaco, e, composto

Info

Publication number
BRPI0513456A
BRPI0513456A BRPI0513456-0A BRPI0513456A BRPI0513456A BR PI0513456 A BRPI0513456 A BR PI0513456A BR PI0513456 A BRPI0513456 A BR PI0513456A BR PI0513456 A BRPI0513456 A BR PI0513456A
Authority
BR
Brazil
Prior art keywords
radiopharmaceutical
chelator
chelators
tetraamine
functionalized
Prior art date
Application number
BRPI0513456-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Anthony Eamonn Storey
Harry Wadsworth
Nigel Anthony Powell
Philip Duncanson
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of BRPI0513456A publication Critical patent/BRPI0513456A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0513456-0A 2004-07-19 2005-07-19 complexo de tecnécio, conjugado quelador, radiofármaco, kit para a preparação do radiofármaco, e, composto BRPI0513456A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0416062.8A GB0416062D0 (en) 2004-07-19 2004-07-19 Improved N4 chelator conjugates
PCT/GB2005/002807 WO2006008496A2 (en) 2004-07-19 2005-07-19 Improved n4 chelator conjugates

Publications (1)

Publication Number Publication Date
BRPI0513456A true BRPI0513456A (pt) 2008-05-06

Family

ID=32893775

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513456-0A BRPI0513456A (pt) 2004-07-19 2005-07-19 complexo de tecnécio, conjugado quelador, radiofármaco, kit para a preparação do radiofármaco, e, composto

Country Status (14)

Country Link
US (1) US7767796B2 (enExample)
EP (1) EP1768708B1 (enExample)
JP (1) JP5557425B2 (enExample)
KR (2) KR20070034064A (enExample)
CN (1) CN101128219B (enExample)
AU (1) AU2005263942B2 (enExample)
BR (1) BRPI0513456A (enExample)
CA (1) CA2573384C (enExample)
ES (1) ES2628935T3 (enExample)
GB (1) GB0416062D0 (enExample)
MX (1) MX2007000744A (enExample)
NO (1) NO20070348L (enExample)
RU (1) RU2360701C2 (enExample)
WO (1) WO2006008496A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI448284B (zh) * 2007-04-24 2014-08-11 Theravance Inc 雙效抗高血壓劑
CN101732736B (zh) * 2009-12-02 2012-04-04 北京师范大学 制备锝-99m标记的DTPA-LSA的药盒及制备方法和应用
GB0922014D0 (en) 2009-12-17 2010-02-03 Ge Healthcare Ltd Novel integrin binders
GB201016206D0 (en) * 2010-09-27 2010-11-10 Ge Healthcare Ltd Apoptosis imaging agents
RU2465011C1 (ru) * 2011-04-27 2012-10-27 Общество с ограниченной ответственностью "ИНТЕРА-МЕД" Радиофармацевтический препарат для диагностики меланомы и ее метастазов
GB201110767D0 (en) 2011-06-24 2011-08-10 Ge Healthcare Ltd Infection imaging
GB201600161D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope purification method
RU2655392C1 (ru) * 2017-03-02 2018-05-28 Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский политехнический университет" Способ получения комплекса технеция-99м с октреотидом для диагностики нейроэндокринных опухолей
CN112105393A (zh) 2018-05-16 2020-12-18 爱默蕾大学 苯乙烯基苯并噻唑衍生物及在成像中的用途
US20250215027A1 (en) * 2021-08-11 2025-07-03 Cancer Research Technology Limited Diphosphine compounds and complexes

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175343A (en) * 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
ATE66469T1 (de) * 1985-01-14 1991-09-15 Neorx Corp Metall-radionuklid markiertes protein fuer diagnose und therapie.
US5242679A (en) * 1985-01-14 1993-09-07 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
JPH02504387A (ja) * 1987-04-02 1990-12-13 セントカー・カーデイオバスキユラー・イメージング・パートナーズ・エルピー 金属イオンで抗体を標識付けする方法
US4952393A (en) * 1987-04-02 1990-08-28 The General Hospital Corporation Organ infarct imaging with technetium labelled glucarate
US5489425A (en) * 1987-06-24 1996-02-06 The Dow Chemical Company Functionalized polyamine chelants
US4994560A (en) * 1987-06-24 1991-02-19 The Dow Chemical Company Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
NO940080L (no) * 1993-01-12 1994-07-13 Sandoz Ag Polypeptider , fremgangsmåte for deres fremstilling og farmasöytiske preparater derav
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
CA2232411A1 (en) * 1995-09-18 1997-03-27 Mallinckrodt Medical, Inc. (radio) labelled biotin derivatives
GR1003661B (el) * 2000-05-25 2001-09-05 Εθνικο Κεντρο Ερευνας Φυσικων Επιστημων (Εκεφε) "Δημοκριτος"... ΣΥΝΘΕΣΗ, ΒΙΟΛΟΓΙΚΗ ΚΑΙ ΠΡΟΚΛΙΝΙΚΗ ΑΞΙΟΛΟΓΗΣΗ ΑΝΑΛΟΓΩΝ ΤΗΣ (D-Phe6, Leu-NHEt13, des-Met14)-ΒΟΜΒΕΣΙΝΗΣ (6-14)ΤΡΟΠΟΠΟΙΗΜΕΝΩΝ ΜΕ ΠΑ ΡΑΓΩΓΑ ΤΟΥ 1,4,8,11-ΤΕΤΡΑΑΖΑΕΝΔΕΚΑΝΙΟΥ(1,4,8,11-TETRAAZAUNDECAN E)ΚΑΙ ΕΠΙΣΗΜΑΣΜΕΝΩΝ ΜΕ ΤΕΧΝΗΤΙΟ-99M- ΓΙΑ ΕΦΑΡΜΟΓΗ ΣΤΗΝ ΟΓΚΟΛΟΓ
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
CN1622830A (zh) * 2001-07-10 2005-06-01 安盛药业有限公司 肽基化合物
GB0130305D0 (en) 2001-12-19 2002-02-06 Amersham Plc Compounds for imaging alzheimers disease
US7785566B2 (en) * 2003-11-06 2010-08-31 Ge Healthcare, Inc. Pharmaceutical compounds
US7431914B2 (en) * 2003-11-24 2008-10-07 Ge Healthcare As Contrast agent
CN1925876A (zh) * 2004-03-04 2007-03-07 通用电气医疗集团股份有限公司 用于诊断和治疗的血管紧张素肽类似物和螯合剂的缀合物

Also Published As

Publication number Publication date
AU2005263942B2 (en) 2009-02-26
EP1768708A2 (en) 2007-04-04
MX2007000744A (es) 2007-06-25
CN101128219B (zh) 2012-06-20
CN101128219A (zh) 2008-02-20
CA2573384C (en) 2013-09-10
US7767796B2 (en) 2010-08-03
US20080131368A1 (en) 2008-06-05
KR20070034064A (ko) 2007-03-27
EP1768708B1 (en) 2017-05-17
CA2573384A1 (en) 2006-01-26
NO20070348L (no) 2007-02-16
GB0416062D0 (en) 2004-08-18
KR20130024963A (ko) 2013-03-08
AU2005263942A1 (en) 2006-01-26
WO2006008496A3 (en) 2006-07-27
ES2628935T3 (es) 2017-08-04
JP2008510683A (ja) 2008-04-10
JP5557425B2 (ja) 2014-07-23
RU2360701C2 (ru) 2009-07-10
WO2006008496A2 (en) 2006-01-26
RU2007101515A (ru) 2008-08-27

Similar Documents

Publication Publication Date Title
NO20070348L (no) Improved N4 Chelator Conjugates
Liu Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides
Kubicek et al. Gallium (III) complexes of DOTA and DOTA− monoamide: kinetic and thermodynamic studies
Schibli et al. In vitro and in vivo evaluation of bidentate, water-soluble phosphine ligands as anchor groups for the organometallic fac-[99mTc (CO) 3]+-core
NO20074025L (no) Konjugater for dobbel billeddannelse og radiokjemoterapi:sammensetninger, fremstilling og anvendelse
MX2021013055A (es) Inhibidores de antigenos de membrana especificos de prostata (psma) como agentes diagnosticos y terapeuticos con radionuclidos.
Pitchumony et al. Isostructural nuclear and luminescent probes derived from stabilized [2+ 1] rhenium (I)/technetium (I) organometallic complexes
Ferreira et al. Carbohydrate-appended 3-hydroxy-4-pyridinone complexes of the [M (CO) 3]+ core (M= Re, 99mTc, 186Re)
Liu et al. Labeling biomolecules with radiorhenium-A review of the bifunctional chelators
Méndez-Rojas et al. Recent advances on technetium complexes: coordination chemistry and medical applications¶
JPH01113349A (ja) ８−ヒドロキシキノリン単位からなる多座キレート化剤
AU6968301A (en) Small technetium-99m and rhenium labeled agents and methods for imaging tumors
NO20051811L (no) Conjugates of TC complexes and targeting moiettes and their use in mri diagnostic
Ferreira et al. Cationic technetium and rhenium complexes with pendant carbohydrates
El-Zaria et al. Room-temperature synthesis of Re (I) and Tc (I) metallocarboranes
Kramer et al. Derivatives of 1, 3, 5-triamino-1, 3, 5-trideoxy-cis-inositol as versatile pentadentate ligands for protein labeling with Re-186/188. prelabeling, biodistribution, and X-ray structural studies
JP5152821B2 (ja) 放射線治療用化学毒性剤としての金属トリカルボニル錯体の使用
Bowen et al. Long-chain rhenium and technetium glucosamine conjugates
PT871608E (pt) Novos derivados monofuncionais de edta dtpa e ttha e sua utilizacao no diagnostico medicos e terapia
Panwar et al. Synthesis, characterization, and in vivo skeletal localization of a new 99mTc-based multidentate phosphonate chelate: 5-Amino-1, 3-bis (ethylamine-(N, N dimethyl diphosphonic acid) acetamido) benzene
Zhang et al. Synthesis of a bis-(N-sec-butyl-dithiocarbamato)-nitrido-99mTc complex: a potential new radiopharmaceutical for brain perfusion studies
BR112013006536A2 (pt) agente de formação de imagem, conjugado quelador, métodos de preparação do agente de formação de imagem, de formar imagem do corpo humano ou de animal e de diagnóstico do corpo humano ou animal, composição radiofarmacêutica, kit para a preparação da composição radiofarmacêutica, e, uso do agente de formação de imagem, da composição ou do kit
Dhara et al. New oxorhenium (V) complexes with 2N2S donor sets and radiochemical behavior of their technetium analogs
Wei et al. Rhenium tricarbonyl core complexes with ligands derived from arylpiperazines. The structures of [Re (CO) 3 {NC5H4CH2N (H) CH2CH2–Fphenpip}] Br,[Re (CO) 3 {(NC5H4CH2) 2N (CH2) 3–CH3OphenpipH}] Br2 and [Re (CO) 3 {(CH3N2C3H2CH2)(O2CCH2) N (CH2) 3–CH3OphenpipH2}] BrCl
US6515112B2 (en) Cores for technetium radiopharmaceuticals

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2315 DE 19-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.